Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 37.45 M33.33 M— — Research & development 10.73 M13.71 M— — Operating income 3.72 M7.53 M-2.63 M — Non-Operating Income, Total -27.96 M852 K— — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 708 K1.99 M— — Unusual income/expense -28.67 M-1.14 M— — Pretax income -24.24 M8.38 M-2.63 M — Equity in earnings ——— — Taxes 1.99 M1.95 M— — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -26.23 M-6.44 M34.48 M — Discontinued operations ——— — Net income -26.23 M-6.44 M34.48 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 26.23 M6.44 M-47.35 M — Basic earnings per share (Basic EPS) -0.650.09— — Diluted earnings per share (Diluted EPS) -0.650.080.68 — Average basic shares outstanding 27.66 M43.17 M50.9 M — Diluted shares outstanding 27.66 M43.17 M50.9 M — EBITDA 4.42 M8.23 M— — EBIT 3.72 M7.53 M— — Cost of revenue 15.9 M14.79 M— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 700 K700 K2.63 M —